Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses ...

The third and final suspect involved in the burglary in Hull has pleaded guilty. Jesse Van Leeuwen was facing the following ...

Recent research published in the Journal of Psychopharmacology suggests that cannabidiol, a non-intoxicating compound found ...

In the phase 2 LiBBY trial presented, tetrahydrocannabinol and cannabidiol reduced agitation scores and improved clinician-rated outcomes in patients with advanced dementia.

Deputy Gavin St Pier is seeking answers about the scale of prescriptions for medicinal cannabis ...

If you’re like a lot of people, you probably fall short of the recommended seven to nine hours of sleep each night — maybe ...

Texas will ban delta-8, delta-10, THCP and other hemp products July 31. Here's what remains legal after the Supreme Court ...

Ashwini Nadkarni, MD, of Mass General Brigham, discusses how the treatment landscape has changed in recent years for generalized anxiety disorder.

In a first-of-its-kind clinical trial, U.S. researchers found that people with agitation and dementia in late life who took a ...

High hopes for those with dementia. New research has found an unexpected benefit for a common symptom in those with ...

"Why would you repeat those damn lies? That destroys trust." -- Sen. Bill Cassidy, MD (R-La.), grilling President Trump's ...

Senator Ron Wyden (D-OR) is working with Democratic leadership to end the federal ban on marijuana.